 Nearly lost in all the noise over the impeachment debacle and constant fear-mongering surrounding the “coronavirus” outbreak, were two notable events involving major career vaccine pushers.In December 2019, news quietly broke that Sue Desmond-Hellman would be stepping down as CEO of Bill & Melinda Gates Foundation. Even more quiet was her announcement 2 months earlier that she would be stepping down as lead director on the board at Facebook.Vox reported that her departure is due to sudden health issues:Now, it appears health issues are causing her to step aside. Desmond-Hellmann also held power as a lead independent director on the board of Facebook, which she announced she was leaving this fall.And as if that wasn’t newsworthy enough in itself, news of another event came across my Twitter feed about former CDC director Julie Gerberding, who is currently enjoying her revolving door rite of passage as an executive at Merck, sold $9.11 million in shares of Merck stock this month. Read Full Article | |
| https://www.finviz.com/insidertrading.ashx?oc=1628884&tc=7 |
Related
Merck’s Vaccine Division President Julie Gerberding Sells $9.1 Million in Shares
https://shore-215.blogspot.com/search?q=Julie+Gerberding+
How The Head Of The CDC Left To Become The Head Of The Vaccine Division At Merck
https://pbs.twimg.com/media/EP-F67TXUAEJVXU?format=jpg&name=medium
No comments:
Post a Comment